Daniel E. Morse serves as Executive at Stellar Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Daniel E. Morse has executed 8 insider transactions totaling $38.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 12, 2018 involved selling 7,047 shares valued at $9.2K.
Daniel E. Morse currently holds 20,741 shares of Stellar Biotechnologies, Inc. (SBOT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel E. Morse has been a net seller of SBOT stock. They have purchased $0 and sold $38.4K worth of shares.
Daniel E. Morse's most recent insider trade was on Oct 12, 2018, when they sold 7,047 shares at $1.31 per share.
Get notified when new Form 4 filings are submitted
| $0.81 |
| Discretionary |
| Mar 12, 2018 | SBOT | $2.8K | Sale | 3,500 | $0.80 | Discretionary |
| Mar 9, 2018 | SBOT | $5.7K | Sale | 7,000 | $0.81 | Discretionary |
| Feb 28, 2018 | SBOT | $5.5K | Sale | 7,000 | $0.79 | Discretionary |
| Feb 26, 2018 | SBOT | $5.5K | Sale | 7,000 | $0.79 | Discretionary |
| Feb 22, 2018 | SBOT | $6.1K | Sale | 7,800 | $0.78 | Discretionary |
| Jun 26, 2017 | SBOT | $0 | Award | 134,680 | $N/A | Discretionary |